- Home
- TRP vs BDX Comparison
TRP vs BDX Comparison
Compare TRP & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRP | BDX |
|---|---|---|
| Founded | 1951 | 1897 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.3B | 55.5B |
| IPO Year | N/A | 1962 |
Fundamental Metrics
Financial Performance| Metric | TRP | BDX |
|---|---|---|
| Price | $53.73 | $203.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $84.00 | ★ $205.25 |
| AVG Volume (30 Days) | ★ 2.0M | 1.9M |
| Earning Date | 02-13-2026 | 02-04-2026 |
| Dividend Yield | ★ 4.58% | 2.05% |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.34 | ★ 5.82 |
| Revenue | $10,516,264,743.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $11.69 | $4.02 |
| Revenue Next Year | $6.23 | $3.37 |
| P/E Ratio | ★ $22.85 | $35.25 |
| Revenue Growth | ★ 24.53 | 8.24 |
| 52 Week Low | $43.51 | $162.29 |
| 52 Week High | $56.34 | $251.99 |
Technical Indicators
Market Signals| Indicator | TRP | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 44.73 | 61.00 |
| Support Level | $52.71 | $201.29 |
| Resistance Level | $56.08 | $206.99 |
| Average True Range (ATR) | 1.03 | 3.56 |
| MACD | -0.29 | 0.65 |
| Stochastic Oscillator | 28.10 | 72.85 |
Price Performance
Historical ComparisonAbout TRP TC Energy Corporation
TC Energy operates natural gas transmission assets across North America. Segments are determined by country of operation, but both Canadian and US operations are interconnected. Mexican operations are disconnected from the US and only have one customer, the state utility CFE. They also operate power generation assets, with the largest being the Bruce Power nuclear plant.
About BDX Becton Dickinson and Company
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.